EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar

Christina A Eichstaedt iD, Gabriel Maldonado-Velez iD, Rajiv D Machado iD, Stefan Gräf iD, Dennis Dooijes, Srimmitha Balachandar iD, Florence Coulet, Kristina Day iD, Melanie Eyries, Daniela Macaya, Memoona Shaukat, Laura Southgate iD und 4 weitere

Human Mutation · 2025-01 · 2025 (1)

DOI: 10.1155/humu/2475635 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Human Mutation, online erschienen am 07.07.2025. Verfasst von Christina A Eichstaedt und 15 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pulmonary Hypertension, Thoraxklinik-Heidelberg gGmbH, Heidelberg University Hospital and Translational Lung Research Center (TLRC), Germa…. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein Receptors, Type II, Pulmonary Arterial Hypertension, Genetic Variation, Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial hypertension (PAH) is a rare disease that can be caused by pathogenic variants, most frequently in the bone Morphogenetic Protein Receptor Type 2 ( BMPR2 ) gene. We formed a ClinGen variant curation expert panel to devise guidelines for the clinical interpretation of BMPR2 variants identified in PAH patients. The general ACMG/AMP variant classification criteria were refined for PAH and adapted to BMPR2 following ClinGen procedures. Subsequently, these specifications were tested independently by three members of the curation expert panel on 28 representative BMPR2 variants selected from ClinVar and then presented and discussed in the plenum. Application of the final BMPR2 variant specifications resolved six of nine variants (66%) where multiple ClinVar classifications included a variant of uncertain significance, with all six being reclassified as Benign or Likely Benign. Four splice site variants underwent clinically consequential reclassification based on the presence or absence of supporting mRNA splicing data. These variant specifications provide an international framework and a valuable tool for BMPR2 variant classification that can be applied to increase confidence and consistency in BMPR2 interpretation for diagnostic laboratories, clinical providers, and patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Morphogenetic Protein Receptors, Type IIPulmonary Arterial HypertensionGenetic VariationMutationHypertension, PulmonaryHumansGenetic Predisposition to DiseasePractice Guidelines as TopicRNA Splicing

Stichwörter der Autor:innen

ACMG/AMP guidelinesBMPR2ClinVarpulmonary arterial hypertensionvariant interpretation

Substanzen

Bone Morphogenetic Protein Receptors, Type IIBMPR2 protein, human

Autor:innen und Institutionen

  • Center for Pulmonary Hypertension, Thoraxklinik-Heidelberg gGmbH, Heidelberg University Hospital and Translational Lung Research Center (TLRC), German Center for Lung Research (DZL), Heidelberg, Baden-Württemberg, Germa…
  • Laboratory for Molecular Genetic Diagnostics, Institute of Human Genetics, Heidelberg University, Heidelberg, Baden-Württemberg, Germany.
  • Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • School of Health & Medical Sciences, City St George's, University of London, London, UK.
  • Department of Medicine, School of Clinical Medicine, University of Cambridge, Victor Phillip Dahdaleh Heart & Lung Research Institute, Cambridge, UK.
  • Department of Genetics, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.

ORCID-Profile: Christina A Eichstaedt, Gabriel Maldonado-Velez, Rajiv D Machado, Stefan Gräf, Srimmitha Balachandar, Kristina Day, Laura Southgate, Jair Tenorio-Castano, Wendy K Chung, Carrie L Welch, Micheala A Aldred

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Eichstaedt, C. A., Maldonado-Velez, G., Machado, R. D., Gräf, S., Dooijes, D., Balachandar, S., Coulet, F., Day, K., Eyries, M., Macaya, D., Shaukat, M., Southgate, L., Tenorio-Castano, J., Chung, W. K., Welch, C. L., & Aldred, M. A. (2025). Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar. Human Mutation, 2025(1). https://doi.org/10.1155/humu/2475635

Vancouver

Eichstaedt CA, Maldonado-Velez G, Machado RD, Gräf S, Dooijes D, Balachandar S, et al. Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar. Human Mutation. 2025;2025(1). doi:10.1155/humu/2475635

BibTeX
@article{Eichstaedt2025,
  author = {Eichstaedt, Christina A and Maldonado-Velez, Gabriel and Machado, Rajiv D and Gräf, Stefan and Dooijes, Dennis and Balachandar, Srimmitha and Coulet, Florence and Day, Kristina and Eyries, Melanie and Macaya, Daniela and Shaukat, Memoona and Southgate, Laura and Tenorio-Castano, Jair and Chung, Wendy K and Welch, Carrie L and Aldred, Micheala A},
  title = {Adaptation of ACMG/AMP Guidelines for Clinical Classification of BMPR2 Variants in Pulmonary Arterial Hypertension Resolves Variants of Unclear Pathogenicity in ClinVar},
  journal = {Human Mutation},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/humu/2475635}
}
Kostenlos starten →